Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The role of tumor suppressor short non-coding RNAs on breast cancer.
Salimimoghadam S, Taefehshokr S, Loveless R, Teng Y, Bertoli G, Taefehshokr N, Musaviaroo F, Hajiasgharzadeh K, Baradaran B. Salimimoghadam S, et al. Crit Rev Oncol Hematol. 2021 Feb;158:103210. doi: 10.1016/j.critrevonc.2020.103210. Epub 2020 Dec 29. Crit Rev Oncol Hematol. 2021. PMID: 33385514 Review.
Chitosan-based nanoscale delivery systems in hepatocellular carcinoma: Versatile bio-platform with theranostic application.
Karimi K, Mojtabavi S, Tehrany PM, Nejad MM, Rezaee A, Mohtashamian S, Hamedi E, Yousefi F, Salmani F, Zandieh MA, Nabavi N, Rabiee N, Ertas YN, Salimimoghadam S, Rashidi M, Rahmanian P, Hushmandi K, Yu W. Karimi K, et al. Among authors: salimimoghadam s. Int J Biol Macromol. 2023 Jul 1;242(Pt 3):124935. doi: 10.1016/j.ijbiomac.2023.124935. Epub 2023 May 23. Int J Biol Macromol. 2023. PMID: 37230442 Review.
LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions.
Entezari M, Taheriazam A, Orouei S, Fallah S, Sanaei A, Hejazi ES, Kakavand A, Rezaei S, Heidari H, Behroozaghdam M, Daneshi S, Salimimoghadam S, Mirzaei S, Hashemi M, Samarghandian S. Entezari M, et al. Among authors: salimimoghadam s. Biomed Pharmacother. 2022 Oct;154:113609. doi: 10.1016/j.biopha.2022.113609. Epub 2022 Aug 27. Biomed Pharmacother. 2022. PMID: 36037786 Free article. Review.
Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy.
Hashemi M, Moosavi MS, Abed HM, Dehghani M, Aalipour M, Heydari EA, Behroozaghdam M, Entezari M, Salimimoghadam S, Gunduz ES, Taheriazam A, Mirzaei S, Samarghandian S. Hashemi M, et al. Among authors: salimimoghadam s. Pharmacol Res. 2022 Oct;184:106418. doi: 10.1016/j.phrs.2022.106418. Epub 2022 Aug 28. Pharmacol Res. 2022. PMID: 36038043 Review.
Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance.
Hashemi M, Hajimazdarany S, Mohan CD, Mohammadi M, Rezaei S, Olyaee Y, Goldoost Y, Ghorbani A, Mirmazloomi SR, Gholinia N, Kakavand A, Salimimoghadam S, Ertas YN, Rangappa KS, Taheriazam A, Entezari M. Hashemi M, et al. Among authors: salimimoghadam s. Pharmacol Res. 2022 Dec;186:106535. doi: 10.1016/j.phrs.2022.106535. Epub 2022 Nov 2. Pharmacol Res. 2022. PMID: 36334877 Review.
STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response.
Sadrkhanloo M, Entezari M, Orouei S, Ghollasi M, Fathi N, Rezaei S, Hejazi ES, Kakavand A, Saebfar H, Hashemi M, Goharrizi MASB, Salimimoghadam S, Rashidi M, Taheriazam A, Samarghandian S. Sadrkhanloo M, et al. Among authors: salimimoghadam s. Pharmacol Res. 2022 Aug;182:106311. doi: 10.1016/j.phrs.2022.106311. Epub 2022 Jun 15. Pharmacol Res. 2022. PMID: 35716914 Review.
Non-coding RNAs targeting notch signaling pathway in cancer: From proliferation to cancer therapy resistance.
Hashemi M, Hasani S, Hajimazdarany S, Mirmazloomi SR, Makvandy S, Zabihi A, Goldoost Y, Gholinia N, Kakavand A, Tavakolpournegari A, Salimimoghadam S, Nabavi N, Zarrabi A, Taheriazam A, Entezari M, Hushmandi K. Hashemi M, et al. Among authors: salimimoghadam s. Int J Biol Macromol. 2022 Dec 1;222(Pt A):1151-1167. doi: 10.1016/j.ijbiomac.2022.09.203. Epub 2022 Oct 1. Int J Biol Macromol. 2022. PMID: 36191781 Review.
SOX2 function in cancers: Association with growth, invasion, stemness and therapy response.
Mirzaei S, Paskeh MDA, Entezari M, Mirmazloomi SR, Hassanpoor A, Aboutalebi M, Rezaei S, Hejazi ES, Kakavand A, Heidari H, Salimimoghadam S, Taheriazam A, Hashemi M, Samarghandian S. Mirzaei S, et al. Among authors: salimimoghadam s. Biomed Pharmacother. 2022 Dec;156:113860. doi: 10.1016/j.biopha.2022.113860. Epub 2022 Oct 20. Biomed Pharmacother. 2022. PMID: 36272267 Free article. Review.
Epigenetic regulation of autophagy by non-coding RNAs in gastrointestinal tumors: Biological functions and therapeutic perspectives.
Zandieh MA, Farahani MH, Rajabi R, Avval ST, Karimi K, Rahmanian P, Razzazan M, Javanshir S, Mirzaei S, Paskeh MDA, Salimimoghadam S, Hushmandi K, Taheriazam A, Pandey V, Hashemi M. Zandieh MA, et al. Among authors: salimimoghadam s. Pharmacol Res. 2023 Jan;187:106582. doi: 10.1016/j.phrs.2022.106582. Epub 2022 Nov 24. Pharmacol Res. 2023. PMID: 36436707 Free article. Review.
47 results